ECR Pharmaceuticals (Amrix Product Line) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

ECR Pharmaceuticals (Amrix Product Line) General Information

Description

North American rights to formulate AMRIX. The drug is used as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute musculoskeletal conditions.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Cephalon
Primary Office
  • P.O. Box 71600
  • Richmond, VA 23255
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ECR Pharmaceuticals (Amrix Product Line) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ECR Pharmaceuticals (Amrix Product Line)‘s full profile, request access.

Request a free trial

ECR Pharmaceuticals (Amrix Product Line) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ECR Pharmaceuticals (Amrix Product Line)‘s full profile, request access.

Request a free trial